As Chief Financial Officer for StrikeIron, Brett oversees the financial direction for all the company's operations. Prior to StrikeIron, he was the Vice President, Finance and served as the chief financial officer for Icoria, Inc. (formerly Paradigm Genetics, Inc.), a publicly traded biotech company that was sold to Monsanto in 2005. Mr. Farabaugh has a diverse background in working with entrepreneurial companies in both the public and private arenas. He was the former Vice President of Finance for Nuada Pharmaceuticals, Inc. Prior to joining Nuada Pharmaceuticals, Mr. Farabaugh served for 12 years in various positions at PricewaterhouseCoopers (PwC), most recently as Senior Manager Global Technology Industry Group. Mr. Farabaugh s experience includes financial management, analysis and reporting, initial public offerings and other exit strategies, extensive due diligence related to investment and acquisitions and fundraising in both the public and private markets. In addition, Mr. Farabaugh was the technical director, editor and contributing author of the benchmarking study Financial Operating Ratios for Software Companies, 1997-98, published by Culpepper and Associates. Mr. Farabaugh earned his degree in Accounting from the University of Virginia.